000 | 01957 a2200493 4500 | ||
---|---|---|---|
005 | 20250516033432.0 | ||
264 | 0 | _c20120521 | |
008 | 201205s 0 0 eng d | ||
022 | _a1433-2965 | ||
024 | 7 |
_a10.1007/s00198-011-1635-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheen, M H H | |
245 | 0 | 0 |
_aAdherence to osteoporosis medications amongst Singaporean patients. _h[electronic resource] |
260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cMar 2012 |
||
300 |
_a1053-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEtidronic Acid _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
650 | 0 | 4 |
_aOsteoporotic Fractures _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisedronic Acid |
650 | 0 | 4 |
_aSingapore _xepidemiology |
650 | 0 | 4 | _aAssessment of Medication Adherence |
700 | 1 | _aKong, M C | |
700 | 1 | _aZhang, R F | |
700 | 1 | _aTee, F M H | |
700 | 1 | _aChandran, M | |
773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 23 _gno. 3 _gp. 1053-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-011-1635-9 _zAvailable from publisher's website |
999 |
_c20769544 _d20769544 |